Does Sugar Make Antibiotic Damage to Your Gut Microbiome Worse? What the New Research Shows

A landmark study published in Nature on September 30, 2026 found that for every additional 100 grams of sugar consumed in the 48 hours before antibiotic treatment, patients experienced a 21% greater decline in gut microbiome diversity — and a dramatic expansion of Enterococcus faecium, a bacterium linked to hard-to-treat hospital infections. The research, led by scientists from NYU Langone Health, Memorial Sloan Kettering Cancer Center, and City of Hope, represents one of the most detailed diet-microbiome datasets ever assembled in a clinical setting.

The core finding is blunt: sugar appears to act as rocket fuel for the harmful bacteria that survive an antibiotic assault, making an already damaging process considerably worse.

How the Study Was Designed — and Why the Data Quality Matters

Before unpacking the numbers, it helps to understand why this study carries more weight than most nutrition research. Dietary studies are notoriously difficult to conduct rigorously because people misremember what they eat. This team solved that problem by studying 173 hospitalized blood cancer patients whose every meal was prepared by the hospital kitchen and recorded in detail.

Researchers tracked 9,419 meals and more than 40,000 individual food items, logging the precise quantity of each ingredient consumed at every sitting. Stool samples were collected daily to monitor microbiome changes. The result was a dataset linking real-time dietary intake to real-time microbial shifts — a level of resolution that is rarely achievable outside a controlled inpatient setting.

"I think this is the closest anyone has ever come to precisely recording everything that goes in and linking it to what comes out," said co-senior author Jonathan Peled of Memorial Sloan Kettering, as reported by New Scientist.

The patients were undergoing haematopoietic stem cell transplantation (bone marrow transplant), a procedure that requires weeks of hospitalization, intensive chemotherapy, and prophylactic antibiotic treatment. This made them an ideal study population: high antibiotic exposure, precisely controlled food environment, and daily biological sampling.

Key Findings at a Glance

The table below summarizes the central quantitative findings across the human cohort and the mouse experiments, allowing a direct comparison of effect sizes.

Condition	Metric	Observed Effect	Source
Humans: +100g sugar in 48h before antibiotics	Alpha diversity (gut bacterial variety)	21% greater decline	NYU Langone / Nature, 2026
Humans: high-sugar diet + antibiotics	Enterococcus faecium abundance	Significant bloom vs. low-sugar group	ScienceDaily, Oct 2026
Mice: antibiotic biapenem + dietary sucrose, Day 3	Gut Enterococcus population	16.3-fold increase	Nature paper via NYU Langone
Mice: antibiotic biapenem + dietary sucrose, Day 6	Gut Enterococcus population	33.4-fold increase	Nature paper via NYU Langone
Mice: high-sugar diet alone (no antibiotics)	Gut bacterial diversity	No significant disruption	New Scientist, Sept 2026
Humans: above-average sugar intake post-transplant	Mortality risk (observational)	~12% higher risk of death	Times of India, Oct 2026

The mouse data is particularly striking because it isolates the sugar variable. Animals given antibiotics alone showed only a modest Enterococcus increase. Animals given antibiotics plus sucrose showed a 33-fold increase by day six. Animals given sugar alone — without antibiotics — maintained their bacterial diversity. This suggests the effect is not simply "sugar is bad for the gut." Sugar becomes dangerous specifically in the context of antibiotic-induced disruption.

What Is Alpha Diversity, and Why Does It Matter?

Alpha diversity measures the variety of microbial species within a single environment — in this case, a person's gut. A higher alpha diversity score means more different types of bacteria are present and coexisting, which is generally considered a marker of a healthy, resilient gut microbiome.

A diverse microbiome resists colonization by pathogens because beneficial bacteria compete for the same nutrients and physical space that harmful species need to establish themselves. When antibiotics reduce that diversity, the competitive landscape collapses. Surviving bacteria — including dangerous ones — face far less opposition and can expand rapidly.

The 21% greater decline in alpha diversity per 100 grams of sugar is not a trivial number. As New Scientist reports, 100 grams of sugar is roughly equivalent to one large milkshake — a quantity that is easy to consume without thinking twice, particularly if you are following common clinical advice to drink nutritional supplements during illness.

Why Did Researchers Focus on Blood Cancer Patients?

The choice of study population was deliberate and scientifically sound, even if it limits how broadly the findings can be applied. Blood cancer patients undergoing stem cell transplantation receive some of the most intensive antibiotic regimens in medicine. They are hospitalized for weeks, their immune systems are intentionally suppressed by chemotherapy, and their gut microbiomes are subjected to severe and prolonged disruption.

This creates a high-signal environment. The microbiome changes are large enough to measure clearly, the dietary data is unusually precise because meals are hospital-controlled, and the clinical stakes are high enough to make the findings medically meaningful.

"Especially in blood cancer patients, microbiome injury is associated with worse outcomes, including higher overall mortality and infections," said Jonathan Peled, as quoted in the NYU Langone press release. "An important next step will be to design clinical trials to test whether short-term dietary changes can improve clinical outcomes in patients."

The researchers also noted that patients consuming above-average amounts of sugar had approximately a 12% higher risk of death after transplantation, per Times of India's coverage. This is an observational association, not proof of causation — but it is a signal worth taking seriously.

What Is Enterococcus faecium, and Why Is It Dangerous?

Enterococcus faecium is a gram-positive bacterium that normally exists in small numbers in the human gut but can become a dangerous opportunistic pathogen when the surrounding microbial space is disrupted. It is one of the leading causes of hospital-acquired infections worldwide and is notable for its ability to develop resistance to multiple antibiotics, including vancomycin — a last-resort drug.

In healthy individuals with a diverse gut microbiome, E. faecium is kept in check by competition from other bacteria. When antibiotics wipe out much of that competition, E. faecium can bloom rapidly. The new research shows that dietary sugar appears to accelerate this bloom dramatically — a 33-fold increase in mice by day six of combined antibiotic and sucrose exposure.

"In these patients, harmful bacterial species like Enterococcus faecium often thrive because the rest of the gut space has been 'destroyed,'" the NYU Langone press release explains. The sugar, in effect, provides a ready energy source for the bacteria that survived the antibiotic assault — bacteria that are not necessarily the most beneficial to human health.

What Mechanism Explains the Sugar-Antibiotic Interaction?

The researchers are careful to say the precise mechanism is not yet fully established, but they offer a plausible working model. Antibiotics reduce gut bacterial diversity, leaving a small number of surviving strains — including harmful ones like E. faecium — in an environment with reduced competition. When dietary sugar is also present, those surviving bacteria can metabolize it directly, fueling their expansion.

"The new work identifies dietary sugars as an amplifier of antibiotic-induced microbiome disruption, probably because the harmful bacteria that survive the antibiotics are benefiting from the dietary sugars that they can use to expand," said study second author William Jogia, a PhD student in Jonas Schluter's lab, as quoted by NYU Langone.

There is also a secondary mechanism worth considering. Beneficial gut bacteria — particularly those that produce short-chain fatty acids and support gut barrier integrity — tend to thrive on dietary fiber, not simple sugars. When a patient eats a high-sugar, low-fiber diet during antibiotic treatment, they are simultaneously feeding the harmful survivors and starving the beneficial bacteria that might otherwise help restore balance.

Nicola Segata at the University of Trento offered a complementary perspective to New Scientist: "It makes sense that potential pathogens are boosted by sugar. This could directly favour pathogens that thrive on sugar but might not be able to break down fibre, and also boost them indirectly, because the beneficial bacteria they are competing with aren't getting the fibre they need to recover from the antibiotic assault."

Whether sugar acts through direct metabolic support of E. faecium, by weakening competing beneficial bacteria, or through some other pathway — such as effects on gut immune function or mucus production — remains an open question the researchers say requires further investigation.

Does This Apply to People Taking Antibiotics for Routine Infections?

This is the most important caveat in the entire research story, and the authors are explicit about it. The study population — blood cancer patients undergoing stem cell transplantation — is not representative of someone taking a five-day course of amoxicillin for a sinus infection.

The antibiotic regimens used in transplant settings are typically broader-spectrum, longer in duration, and more aggressive than those prescribed for common infections. The patients' immune systems were also intentionally suppressed by chemotherapy, making them far more vulnerable to opportunistic pathogens. The baseline level of microbiome disruption in this population is substantially greater than what most people experience during a routine antibiotic course.

As Times of India's coverage notes, "The evidence is strongest for the specific high-risk transplant population studied, not for every person taking antibiotics for a routine infection."

That said, the biological mechanisms at play — antibiotic-induced diversity loss, competitive release of surviving pathogens, and sugar as a metabolic fuel for those survivors — are not unique to cancer patients. They are general features of gut ecology. The effect may be smaller in magnitude for someone taking a short antibiotic course, but the directional logic holds.

The researchers themselves suggest the findings reach beyond the hospital. "Many of us are motivated to find ways to protect the microbiome when we or our children are prescribed antibiotics. Limiting the intake of sugary foods offers a potential way to do that," said Jonathan Peled, as reported by New Scientist.

What About Smoothies and Nutritional Supplements?

One of the more practically significant implications of this research concerns a common clinical recommendation. Patients with cancer who are struggling to maintain caloric intake are often advised to drink smoothies, milkshakes, or commercial nutritional supplements to prevent weight loss. Many of these products are high in simple sugars, including fructose.

The researchers tested this scenario directly in mice. Animals fed a commercial fruit smoothie — which contained high levels of fructose — showed similar Enterococcus expansion to those fed sucrose directly, according to New Scientist's reporting. This suggests the effect is not limited to table sugar and may extend to fructose-containing products as well.

"This recommendation might have to be re-evaluated if the individual is also taking antibiotics," said Peled. This does not mean patients should stop eating or abandon nutritional support — malnutrition carries its own serious risks. Rather, it suggests that clinicians and dietitians may need to think more carefully about the sugar content of nutritional supplements prescribed during antibiotic treatment, and whether lower-sugar alternatives might achieve the same caloric goals with less microbiome disruption.

What Practical Steps Does the Research Suggest?

The researchers are careful not to overstate their findings as clinical recommendations, since randomized controlled trials have not yet been conducted. With that caveat clearly stated, the study does point toward a few practical considerations.

Reducing simple sugar intake during and immediately after a course of antibiotics appears biologically sensible based on the available evidence. This means limiting obvious sources — sodas, candy, pastries, sweetened beverages, and high-sugar nutritional supplements — rather than eliminating all carbohydrates. Complex carbohydrates and dietary fiber, by contrast, support the beneficial bacteria that antibiotics tend to suppress.

The timing window highlighted by the study is the 48 hours before and during antibiotic treatment, though the researchers note that the post-treatment recovery period matters too. The gut microbiome can take weeks to months to recover after a course of antibiotics, and dietary choices during that window likely influence the outcome.

Co-senior author Jonas Schluter framed the practical implication directly: "Our study, which used more than 9,000 recorded meals, suggests that modifying diet during and after antibiotics, specifically by reducing sweets intake, could help with that," as quoted by ScienceDaily.

What Are the Study's Limitations?

Responsible interpretation requires acknowledging what this study cannot tell us.

The human component was observational. Patients who ate more sugar may have differed from those who ate less in other ways — disease severity, appetite, treatment intensity, or other dietary factors — that could confound the association. The researchers did substantial statistical work to control for confounders, but observational data cannot fully eliminate this concern.

The population is highly specific. Blood cancer patients undergoing stem cell transplantation are among the most medically complex patients in existence. Extrapolating the magnitude of the effect to healthy adults taking a short antibiotic course requires caution.

The mechanism remains incompletely understood. Whether sugar directly fuels E. faecium growth, indirectly harms beneficial bacteria by displacing fiber, or acts through immune or mucosal pathways is not yet established. The mouse experiments support the causal direction but cannot fully replicate human gut complexity.

The mortality association — a 12% higher risk of death in patients with above-average sugar intake — is also observational and cannot establish causation. Sicker patients may eat more sugar (or less fiber) for reasons unrelated to the sugar itself.

The researchers are explicit that clinical trials are the necessary next step. "An important next step will be to design clinical trials to test whether short-term dietary changes can improve clinical outcomes in patients," said Peled, as quoted by NYU Langone.

Why This Research Matters for the Broader Field of Microbiome Science

The gut microbiome has emerged as a central factor in human health far beyond digestion. Research has linked microbiome diversity to immune function, mental health, metabolic regulation, cancer treatment response, and overall mortality. The possibility that a simple dietary choice — reducing sugar intake during antibiotic treatment — could meaningfully protect this space is both scientifically significant and practically accessible.

As the Nature commentary by Mengxi Du and Andrew T. Chan of Harvard Medical School notes, this research demonstrates that diet can influence the severity of antibiotic-induced microbial disturbance — a finding with implications for how clinicians counsel patients before and during antibiotic courses.

The study also highlights the value of detailed dietary data in microbiome research. Most studies in this field rely on self-reported dietary questionnaires, which are notoriously imprecise. The hospital meal-tracking system used here — where every ingredient in every meal was recorded — represents a methodological advance that other research groups may seek to replicate.

For anyone interested in protecting their gut health during antibiotic treatment, the evidence now points in a clear direction: the microbiome is vulnerable during antibiotic exposure, sugar appears to make that vulnerability worse, and reducing simple sugar intake during this window is a low-risk, biologically plausible strategy worth considering. Whether it translates into measurable clinical benefits for the general population awaits the randomized trials the researchers are now calling for.

If you are interested in related topics on gut health and supplementation, you may also find useful context in our coverage of berberine for blood sugar and insulin resistance and best carb blocker supplements for post-meal glucose control, both of which touch on how dietary sugar metabolism intersects with broader health outcomes.